Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-017363
Filing Date
2020-06-22
Accepted
2020-06-22 16:18:52
Documents
1
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3918
  Complete submission text file 0000899243-20-017363.txt   5359
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BRISTOL-MYERS SQUIBB COMPANY RT 206 & PROVINCE LINE ROAD PRINCETON NJ 08540
Business Address
Biondi Paul (Reporting) CIK: 0001744508 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 20979052